Skila Leads Sr. Executive Panel Discussion at the Bridging the Business
Development/Alliance Management Interface Conference
Morris Plains, NJ, October
10, 2007 – Skila, A Sela2 Company, has been requested to lead
a Senior Executive panel discussion at the Cambridge Healthtech Institute
(CHI) Bridging the Business Development/Alliance Management Interface
Conference next month. On Thursday, November 8th, Skila will lead
the panel discussion entitled “Bridging the Business Development/Alliance
Management GAP and Beyond.” Senior Pharmaceutical Alliance executives
will discuss their perspectives and best-practices of how cross-functional
teams should work together in managing the process of defining, shadowing,
governing, viewing, assessing, managing and communicating the performance
of opportunities and shared assets – even after becoming fully
functional alliances.
The Bridging the Business Development/Alliance Management Interface
conference recognizes the model for development of new Pharmaceutical
products is changing rapidly and Pharma must respond. Alternative
sourcing programs are emerging; alliances are becoming more and more
central to new product development as alliance centric external development
programs emerge; and movements towards better integration of business
development and alliance management functions are key to the integration
of alliances. In addition, acquisitions are transforming how companies
are finding, evaluating, structuring and negotiating deals and working
with their external partners. For Business Development and Alliance
Management Teams to effectively work together, both must be equipped
to quickly view, assess, manage and communicate key performance indicators
and milestones that enable, through mutual governance and performance
management, effective outcomes specific to opportunities and potential
assets.
Susan Dorfman, VP of Worldwide Marketing, Skila, will act as the moderator
and the impressive list of current panel experts include Mike Leonetti,
Chairman, Board of Directors, ASAP, Executive Director, Healthcare
Partnerships, Boehringer-Ingelheim Pharmaceuticals, Inc.; Kimberly
Brue, Director, Alliance Management, Sanofi Pasteur; Ratnakar Mitra,
Vice President, Alliance Management and Licensing, Schering Plough;
Kathleen Holt, Ph.D., Senior Director Alliance and Project Management,
Lexicon Pharmaceutical; Moish Tov, CEO, Skila.
About Skila
Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams. These solutions include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global Pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and over 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the long-term growth and adoption of our methodology, technology and continuous services as the business platform of choice for many of our clients.
